Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Dr. John Prensner, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Deciphering mutually exclusive T-ALL and neurodevelopmental mutations in the ARD domain of the ZMIZ1 coactivator
Deciphering mutually exclusive T-ALL and neurodevelopmental mutations in the ARD domain of the ZMIZ1 coactivator
Dr. Mark Chiang, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Preclinical evaluation of omacetaxine as a novel therapeutic for ATRT
Dr. John Prensner, M.D., Ph.D. – University of Michigan Medical Center (Michigan Medicine), Ann Arbor, MI
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
Characterizing the ENL YEATS epigenetic reading domain as a therapeutic target in pediatric MLL-ENL leukemias
The Regents of the University of Michigan, Ann Arbor, MI
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
L3MBTL3, A Therapeutic Target in Acute Myeloid Leukemia
The Regents of the University of Michigan, Ann Arbor, MI